In this segment, Dr. Gregory Vidal discusses the role of estrogen receptor antagonists in the treatment of ER-positive, ...

Cumulative incidence of ipsilateral invasive breast cancer similar when iiBCs detected at primary surgery in the standard treatment group were considered.

In this segment, Dr. Gregory Vidal explains how hormone, or endocrine, therapies work to slow or stop cancer growth in ...

Some say it’s ‘bad medicine’ not to be prescribing it more to high-risk patients, whereas others think alternative approaches might be better.

The fight between these two GLP-1 stocks has now entered round two. Novo Nordisk's Wegovy pill received approval in December, ...

A longstanding mystery in mosquito biology has been solved, opening a potential new path for controlling mosquitoes and the ...

Active surveillance is gaining traction for women with low-risk DCIS, but key questions on patient selection and long-term safety remain.

Learn how nutrients like calcium, protein, omega-3s, and magnesium may support energy, mood, bone health, and overall ...

Popular diet tweaks may boost the hormone a little, but the effect on your pecs is likely to be limited ...

Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for oncology and other therapeutic areas, today announced that ...

The veteran correspondent and 'CNN News Central' co-anchor reveals her behind-the-cameras struggles facing stage 3 breast ...

Experts assess how patent expiry of semaglutide is reshaping GLP-1 pricing and patient access: Shardul Nautiyal, Mumbai Wednesday, April 8, 2026, 08:00 Hrs [IST] India is experien ...